Genapta

Genapta is a company that specializes in providing advanced optical platforms tailored for pharmaceutical screening, DNA sequencing, and genomic testing. Founded in 2001, the company aims to empower pharmaceutical screening and genomic testing with next-level, high-performance optical platforms. Its exclusive optical core allows screening of chemical compounds down to a few molecules, DNA sequencing, and imaging of two-dimensional arrays of fluorophores on surfaces. The devices feature a compact, fiber-coupled head design that enables remote placement (less than 5 meters) of lasers and sensitive detectors. Notably, replacement of lasers or detectors can be done on-site within five minutes with no requirement for re-alignment. The technology boasts intrinsic confocality, supporting femtoliter-scale sample volumes, and eliminating the need for periodic optimization due to its ruggedized technology from the telecom sector. This results in robust performance over its lifecycle. With its focus on the health care industry, Genapta’s technology significantly elevates the performance and cost-efficiency of optical platform design, making it a promising venture for potential investors.